Core Insights - The company emphasizes the significance of participating in the Supply Chain Expo for three consecutive years, showcasing its strength in the entire industry chain and its commitment to sustainable and controllable biomanufacturing supply chains [1][2] - The transition from an industrial chain to an ecological chain is marked by overcoming technical barriers, upgrading industry standards, and addressing global supply chain fluctuations [2][5] - The company has established the world's largest synthetic biology pilot transformation platform in Tianjin, investing over 1 billion yuan to assist upstream and downstream enterprises in overcoming the challenges of transitioning from laboratory to industrialization [2][6] Industry Developments - The company is actively involved in the formulation of industry standards, having led or participated in the establishment of six national industry standards related to hyaluronic acid, thereby enhancing its authority in the global market [5][6] - The integration of artificial intelligence with life sciences is identified as a significant trend, enhancing research efficiency and accelerating the commercialization of scientific achievements [5][6] - The company has formed a strategic partnership with a leading domestic intelligent robotics company to deepen its smart manufacturing layout, improving production efficiency and product quality through advanced robotics and intelligent systems [5][6] Future Outlook - The Chinese biomanufacturing industry is at an early development stage, presenting a unique opportunity for companies to become global supply chain rule-makers by increasing technological investment and embracing new information technologies [6] - Continuous exploration of artificial intelligence, big data, and industrial internet applications in production is essential for companies to transition from "Made in China" to "Intelligent Manufacturing in China" and to lead the global value chain [6]